Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study

Leonardo Solaini,Fabrizio D'Acapito,Alessandro Passardi,Massimo Framarini,Francesca Tauceri,Daniela Di Pietrantonio,Giovanni Luca Frassineti,Andrea Casadei Gardini,Alessandro Cucchetti,Davide Cavaliere,Giorgio Ercolani

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study

2019

Leonardo Solaini
Fabrizio D'Acapito
Alessandro Passardi
Massimo Framarini
Francesca Tauceri
Daniela Di Pietrantonio
Giovanni Luca Frassineti
Andrea Casadei Gardini
Alessandro Cucchetti
Davide Cavaliere
Giorgio Ercolani

Background In this study, we report our experience of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) in patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC), focusing on the factors affecting survival.

Keywords:

General surgery
Hyperthermic intraperitoneal chemotherapy
Colorectal cancer
Cohort study
Oncology
Surgical oncology
Single Center
Medicine
Internal medicine
Hazard ratio
Peritoneal Cancer Index
Proportional hazards model
Gastroenterology
Conventional PCI
Interquartile range

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations